Clinical Trials

Clinical Trials

SAGE Centers is focused on providing outstanding patient care.  We also participate in clinical trials designed to find new treatments, and we share information about clinical trials our partners are leading.

Please check this page for clinical trial posts. You may also follow us on Facebook, LinkedIn, Twitter and Instagram to receive updates.

Aratana and SAGE

We’re conducting a clinical study for dogs with osteosarcoma who have undergone amputation and chemotherapy. There are eligibility requirements for your dog to participate in the study for the conditionally licensed Canine Osteosarcoma Vaccine, Live Listeria Vector and your veterinarian will review your dog’s medical history, perform a physical exam, take thoracic radiographs, and submit routine blood and urine tests. If you would like to learn more, please contact SAGE Centers at for more information.

ImpriMed and SAGE

Improving Future Care for Lymphoma Patients
SAGE invites you and your dog to participate in our long-term research study with ImpriMed, a Palo Alto-based company headed by researchers trained at Stanford University. ImpriMed creates personalized drug combinations to combat cancer and infectious diseases. With pet owners’ consent, SAGE collects canine lymphoma cells with a non-invasive fine-needle aspirate and gives them to ImpriMed to test different chemotherapeutic drugs and concentrations. While there is no immediate health benefit to your pet, voluntarily donating their cells advances veterinary medicine and gives scientists more opportunities to test drugs and drug combinations that could help pets with cancer in the future. There is no cost to participate in this research study. Your SAGE oncologist will extract the cells during your pet’s regular visit. Speak to your SAGE doctor to learn more about how you and your pet can help advance treatment options for dogs with lymphoma.

PetCure Oncology

PetCure Onocology Osteosarcoma Trial:

PetCure Oncology Lung Tumor Trial:

SAGE & The Hemangiosarcoma Study

Has your dog been diagnosed with hemangiosarcoma? This is a serious and deadly cancer that invades the blood vessels. You may wish to consider enrolling your pet in a clinical study coordinated by Iowa State University. Researchers will be assessing the benefit of an immunotherapy in combination with chemotherapy after surgery to see if your dog’s overall survival time can be extended. You will receive $60 per visit toward treatment costs.

Please contact us now for more information.

Contact this Location

Captcha Code